Not available
Quote | Kuros Biosciences Ltd (OTCMKTS:CSBTF)
Last: | $8.35 |
---|---|
Change Percent: | 0.0% |
Open: | $8.62 |
Close: | $8.35 |
High: | $8.89 |
Low: | $8.35 |
Volume: | 2,400 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Kuros Biosciences Ltd (OTCMKTS:CSBTF)
ZURICH, SWITZERLAND / ACCESSWIRE / April 17, 2024 / Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today. The Annual General Meeting approved the Annual Report, the Annual Financial Statements, and the Consolidated Financial St...
Financial highlights Direct MagnetOs sales grew by 163% to CHF 31.7 million in 2023, climbing from CHF 12.1 million in 2022. Total medical device sales accelerated by 153% from CHF 13.3 million in 2022 to CHF 33.6 million in 2023 The Medical Devices segment achieved a positive EBITDA o...
Message Board Posts | Kuros Biosciences Ltd (OTCMKTS:CSBTF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Kuros Biosciences Ltd Company Name:
CSBTF Stock Symbol:
OTCMKTS Market:
ZURICH, SWITZERLAND / ACCESSWIRE / April 17, 2024 / Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today. The Annual General Meeting approved the Annual Report, the Annual Financial Statements, and the Consolidated Financial St...
Financial highlights Direct MagnetOs sales grew by 163% to CHF 31.7 million in 2023, climbing from CHF 12.1 million in 2022. Total medical device sales accelerated by 153% from CHF 13.3 million in 2022 to CHF 33.6 million in 2023 The Medical Devices segment achieved a positive EBITDA o...
- Company to host conference call and webcast on March 13, 2024, at 3pm CET/10am US EST SCHLIEREN (ZURICH), SWITZERLAND / ACCESSWIRE / March 8, 2024 / Kuros Biosciences ("Kuros" or "the Company"), a leader in next-generation bone graft technologies, today announced that it will report its fu...